Terms: = Lung cancer AND CANT1, ENSG00000171302, 124583, Q8WVQ1, SHAPY, SCAN-1
33 results:
1. Pan-cancer analysis predicts cant1 as a potential prognostic, immunologic biomarker.
Yang W; Liu Z; Liu T
Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
[TBL] [Abstract] [Full Text] [Related]
2. Circ_0001715 accelerated lung adenocarcinoma process by the miR-1322/cant1 axis.
Niu Y; Fan L; Shi X; Wu J; Wang T; Hou X
Diagn Pathol; 2023 Aug; 18(1):91. PubMed ID: 37553672
[TBL] [Abstract] [Full Text] [Related]
3. Predictive value of
Tang S; Zhang Y; Li Y; Zhang Y; Xu Y; Ding H; Chen Y; Ren P; Ye H; Fu S; Lin S
Front Immunol; 2023; 14():1034416. PubMed ID: 36860861
[TBL] [Abstract] [Full Text] [Related]
4. Distinguishing Brain Metastasis Progression From Radiation Effects After Stereotactic Radiosurgery Using Longitudinal GRASP Dynamic Contrast-Enhanced MRI.
Berger A; Lee MD; Lotan E; Block KT; Fatterpekar G; Kondziolka D
Neurosurgery; 2023 Mar; 92(3):497-506. PubMed ID: 36700674
[TBL] [Abstract] [Full Text] [Related]
5. cant1 serves as a potential prognostic factor for lung adenocarcinoma and promotes cell proliferation and invasion in vitro.
Yao Q; Yu Y; Wang Z; Zhang M; Ma J; Wu Y; Zheng Q; Li J
BMC Cancer; 2022 Jan; 22(1):117. PubMed ID: 35090419
[TBL] [Abstract] [Full Text] [Related]
6. Calcium-activated nucleotides 1 (cant1)-driven nuclear factor-k-gene binding (NF-ĸB) signaling pathway facilitates the lung cancer progression.
Gao F; Hu X; Liu W; Wu H; Mu Y; Zhao Y
Bioengineered; 2022 Feb; 13(2):3183-3193. PubMed ID: 35068336
[TBL] [Abstract] [Full Text] [Related]
7. The effect and mechanism of miR-607/cant1 axis in lung squamous carcinoma.
Qiao G; Wang HB; Duan XN; Yan XF
Anticancer Drugs; 2021 Aug; 32(7):693-702. PubMed ID: 33675611
[TBL] [Abstract] [Full Text] [Related]
8. [A Case of Primary Liposarcoma of Pancreas Difficult to Diagnose Preoperatively].
Suzuki A; Matsui H; Tokumitsu Y; Shindou Y; Matsukuma S; Nakajima M; Tomochika S; Yoshida S; Iida M; Suzuki N; Takeda S; Yoshino S; Hazama S; Nagano H
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1921-1923. PubMed ID: 33468873
[TBL] [Abstract] [Full Text] [Related]
9. Response evaluation after immunotherapy in NSCLC: Early response assessment using FDG PET/CT.
Park S; Lee Y; Kim TS; Kim SK; Han JY
Medicine (Baltimore); 2020 Dec; 99(51):e23815. PubMed ID: 33371161
[TBL] [Abstract] [Full Text] [Related]
10. The efficiency of
Tao X; Li N; Wu N; He J; Ying J; Gao S; Wang S; Wang J; Wang Z; Ling Y; Tang W; Zhang Z
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1209-1219. PubMed ID: 32043180
[TBL] [Abstract] [Full Text] [Related]
11. Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case.
Stenman A; Hellgren LS; Jatta K; Hysek M; Zemmler M; Altena R; Nilsson IL; Bränström R; Zedenius J; Juhlin CC
Endocr Pathol; 2020 Mar; 31(1):77-83. PubMed ID: 32016808
[TBL] [Abstract] [Full Text] [Related]
12. [Value of LSR and ADCs in differential diagnosis of hilar and mediastinal lymph nodes in lung cancer].
Cai RF; Cui L; Yin JB; Jiang JQ; Liu J
Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(37):3009-3013. PubMed ID: 30392258
[No Abstract] [Full Text] [Related]
13. Asthmatic Exacerbation as a Cause of False-Positive Whole-Body Iodine Scan in a Patient With Treated Papillary Thyroid Carcinoma.
Chaussé G; Kader T; Abikhzer G; Probst S
Clin Nucl Med; 2018 Apr; 43(4):256-257. PubMed ID: 29504963
[TBL] [Abstract] [Full Text] [Related]
14. Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist
Wieser G; Popp I; Christian Rischke H; Drendel V; Grosu AL; Bartholomä M; Weber WA; Mansi R; Wetterauer U; Schultze-Seemann W; Meyer PT; Jilg CA
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1463-1472. PubMed ID: 28417160
[TBL] [Abstract] [Full Text] [Related]
15. Indolent, Potentially Inconsequential lung cancers in the Pittsburgh lung Screening Study.
Thalanayar PM; Altintas N; Weissfeld JL; Fuhrman CR; Wilson DO
Ann Am Thorac Soc; 2015 Aug; 12(8):1193-6. PubMed ID: 26107281
[TBL] [Abstract] [Full Text] [Related]
16. [A case of advanced pancreas cancer successfully treated by using combined modality therapy].
Sunose Y; Takeyoshi I; Hirai K; Igarashi T; Takahashi K; Yamazaki H; Tanaka K; Takahashi N; Tsukagoshi H; Ogawa H; Yoshinari D; Yokoo H
Gan To Kagaku Ryoho; 2015 Feb; 42(2):241-4. PubMed ID: 25743148
[TBL] [Abstract] [Full Text] [Related]
17. Reproducibility of FDG PET based metabolic tumor volume measurements and of their FDG distribution within.
Kruse V; Mees G; Maes A; D'Asseler Y; Borms M; Cocquyt V; Van De Wiele C
Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):462-8. PubMed ID: 24695005
[TBL] [Abstract] [Full Text] [Related]
18. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial.
Horeweg N; van der Aalst CM; Vliegenthart R; Zhao Y; Xie X; Scholten ET; Mali W; Thunnissen E; Weenink C; Groen HJ; Lammers JW; Nackaerts K; van Rosmalen J; Oudkerk M; de Koning HJ
Eur Respir J; 2013 Dec; 42(6):1659-67. PubMed ID: 23845716
[TBL] [Abstract] [Full Text] [Related]
19. Dual time point positron emission tomography/computed tomography scan in evaluation of intrathoracic lesions in an area endemic for histoplasmosis and with high prevalence of sarcoidosis.
Kadaria D; Archie DS; SultanAli I; Weiman DS; Freire AX; Zaman MK
Am J Med Sci; 2013 Nov; 346(5):358-62. PubMed ID: 23276900
[TBL] [Abstract] [Full Text] [Related]
20. ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma.
Hartridge-Lambert SK; Schöder H; Lim RC; Maragulia JC; Portlock CS
Cancer; 2013 Mar; 119(6):1203-9. PubMed ID: 23132361
[TBL] [Abstract] [Full Text] [Related]
[Next]
